ICHS Symposium Program

Scientific Program - please note that this agenda is subject to change. 

 ICHS Preliminary Program and Faculty

Up to 18 hours of Physician and Pharmacist credits may be available.

Meet the Keynote Speaker:

Katy Rezvani, MD, PhD, FRCP, FRCPath
VP & Head, Institute for Cellular Therapy
Professor of Medicine
Chief, Section of Cellular Therapy, Department of Stem Cell Transplant and Cellular Therapy
The University of Texas MD Anderson Cancer Center
Houston, Texas USA

Keynote Speaker Spotlight: Advancing the Frontiers of Cellular Immunotherapy 

Join us for a keynote presentation by Katy Rezvani, MD, PhD, FRCP, FRCPath, whose groundbreaking work in CAR NK cell therapies is redefining what’s possible in cancer treatment. With a focus on developing innovative natural killer (NK) cell–based therapies, Dr. Rezvani and her team are working to offer new treatment options for patients who have exhausted all standard therapies.

Her research demonstrates how engineering NK cells with chimeric antigen receptors (CARs) can overcome resistance, enhance efficacy, and broaden the reach of immunotherapy beyond current limitations. Seeing patients with no remaining treatment options achieve remission underscores both the urgency and promise of this work—and its potential to transform outcomes across multiple cancer types.

Don’t miss this opportunity to hear firsthand how next-generation CAR NK therapies are moving from bench to bedside and reshaping the future of oncology!

Biography

Katy Rezvani, MD, PhD is a professor of medicine at the University of Texas MD Anderson Cancer Center, where she serves as the Vice President & Head, Cell Therapy Institute for Discovery and Innovation, Sally Cooper Murray Chair in Cancer Research, and medical director of the GMP Facility. She leads a research lab with a focus on NK cell biology and developing novel NK cell engineering strategies for cancer, with the aim of translating these discoveries to the clinic.

Dr. Rezvani completed her medical training at University College London, England and her PhD at Imperial College London. She completed her training in immunology and transplantation biology at the National Institutes of Health, Bethesda, MD. In addition, she has co-authored over 250 peer-reviewed publications and received multiple prizes and awards, including the American Society of Hematology E. Donnall Thomas award.